U.S. Senate passes resolution condemning pro-Palestinian campus activism amidst escalating speech suppression
Amidst rising tensions and a national debate, voices on U.S. campuses and workplaces face severe backlash for speaking out on the Israel-Gaza conflict, raising pivotal questions about free speech and the price of political expression in America.
Methane emissions from food waste alarmingly accelerate climate crisis
As EPA reports highlight the staggering methane emissions from food waste, the U.S. grapples with an overlooked environmental hazard.
How U.S. policy failures have helped Hamas
To begin with, Washington has failed to be an honest broker in the peace process.
Examining Israel’s alleged human rights violations amidst global calls for ceasefire
Israel's escalating conflict: unveiling alleged human rights violations and the global cry for a ceasefire.
Goldman Sachs’ electricity ambitions: a dangerous power play
As Goldman Sachs moves to sell retail electricity, advocates warn of potential exploitation and conflicts of interest, echoing concerns of unchecked Wall Street expansion.
Israeli MP Galit Distel Atbaryan advocates for erasing Gaza, raising alarm
An Israeli Member of Parliament's statement advocating for Gaza to be "erased from the face of the earth" raises alarm and highlights the intensifying rhetoric in the region.
US oil-linked pressure group attacks EU green policies, breaks lobbying rules
It appears that Consumer Choice Center’s activity puts it in breach of EU transparency rules, which require lobbyists to declare their activities on the EU Transparency Register.
Kentucky ‘now a forced-birth state’ after judge reinstates abortion bans
"We must codify the right to abortion in Congress," said Rep. Pramila Jayapal. "Pregnant people deserve to make their own healthcare decisions."
Rivers are key to restoring the world’s biodiversity
Biodiversity is plummeting, but restoring rivers could quickly reverse this disastrous trend.
Psychedelic drug in clinical trial to help stroke victims recover by rewiring brain
Algernon Pharmaceuticals, a Canadian-based company, began its study this week in which stroke participants will be given a microdose of DMT with the hope of minimizing damage and maximizing recovery.